Workboat Indexes

Markets:

Overview

News

Currencies

International

Treasuries

Pfizer (NY:PFE)

25.03 +0.15 (+0.60%)

Official Closing Price Updated: 1:10 PM EST, Dec 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stay informed about the most active stocks in the S&P500 index on Wednesday's session. ↗

Today 14:05 EST

Explore the S&P500 index on Wednesday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest.

Via Chartmill

Moderna (MRNA) Deep-Dive: Navigating the 7.5% Year-End Slide and the Path to a 2028 Recovery

Today 10:37 EST

As of December 24, 2025, Moderna, Inc. (Nasdaq: MRNA) finds itself at a pivotal crossroads in its corporate evolution. Once the definitive success story of the pandemic era, the Cambridge-based...

Via PredictStreet

Topics Initial Public Offering

Sanofi’s $2.2 Billion Strategic Pivot: Deconstructing the Dynavax Acquisition and the Future of Specialty Medicine

Today 10:23 EST

As of today, December 24, 2025, the global pharmaceutical landscape is witnessing a profound consolidation of power within specialty medicine and immunology. Sanofi (NASDAQ: SNY; Euronext: SAN), the...

Via PredictStreet

Topics Artificial Intelligence Economy Intellectual Property

Pfizer Confirms Death Of Patient Enrolled In Hemophilia Drug Study ↗

December 23, 2025

Via Stocktwits

“Setting Up The Second Act” Stock Market (And Sentiment Results)… ↗

Today 9:48 EST

Pfizer stands as one of the world’s largest pharmaceutical companies, with a broad portfolio spanning vaccines, oncology, and immunology.

Via Talk Markets

Is Fidelity Medical Equipment the Ultimate "Forever Fund" for Health Care Investors? ↗

Today 8:05 EST

This basket of 64 medical device stocks could raise its dividend for decades.

Via The Motley Fool

Topics ETFs Government Supply Chain

Novo Nordisk Stock Soars as "Wegovy Pill" Gains FDA Approval, Reshaping Obesity Market

December 23, 2025

Shares of Novo Nordisk (NYSE: NVO) surged more than 8% in early trading on December 23, 2025, after the pharmaceutical giant secured a landmark FDA approval for its high-dose oral semaglutide, branded...

Via MarketMinute

The Next Big Buyout? Abivax Emerges as a Premier M&A Contender for 2026 Amidst Biotech Consolidation Wave

December 23, 2025

As the biotech sector closes out a transformative 2025, one name has risen to the top of every institutional investor's watchlist: Abivax (NASDAQ: ABVX). Following a year of stellar clinical results...

Via MarketMinute

Topics Intellectual Property

Novo Nordisk Breaks the Mold: Oral Obesity Breakthrough Sends Shares to New Heights as Pharma Landscape Shifts

December 23, 2025

BAGSVAERD, Denmark — In a landmark decision that has sent shockwaves through the global pharmaceutical industry, Novo Nordisk (NYSE:NVO) has secured U.S. Food and Drug Administration (FDA) approval for...

Via MarketMinute

Topics Economy

Explore the S&P500 index on Tuesday and find out which stocks are the most active in today's session. ↗

December 23, 2025

Stay informed about the most active stocks in the S&P500 index on Tuesday's session. Discover the stocks that are generating the highest trading volume and driving market activity.

Via Chartmill

Pfizer Reports Patient Death In Marstacimab Hemophilia Extension Study ↗

December 23, 2025

Pfizer disclosed a patient death in a marstacimab hemophilia study, triggering a safety review and reassessment of surgical protocols.

Via Benzinga

The Great Biotech Rebound: How Pricing Clarity Rescued the Drug Sector in 2025

December 23, 2025

After a tumultuous first half of 2025 that saw the pharmaceutical and biotechnology sectors languish under a cloud of regulatory dread, the industry is ending the year on a surprisingly high note. The...

Via MarketMinute

Topics Economy

The Great Consolidation: Why 2026 is Set to Become the 'Year of the Mega-Deal'

December 22, 2025

As the curtain closes on 2025, the global financial landscape is witnessing a seismic shift in corporate strategy. After two years of "wait-and-see" posturing dictated by high interest rates and...

Via MarketMinute

Topics Artificial Intelligence Economy Government

The Biotech Renaissance: Innovation and M&A Frenzy Spark a Historic Year-End Rally

December 22, 2025

As the curtains draw on 2025, the biotechnology sector has emerged as the undisputed champion of the equity markets, staging a dramatic year-end rally that has caught even the most optimistic analysts...

Via MarketMinute

Topics ETFs Economy Intellectual Property

The Incretin Empire: Eli Lilly’s (LLY) Path to a $1 Trillion Market Cap and Beyond

December 22, 2025

As of December 22, 2025, the global equity markets are witnessing a historic recalibration of the healthcare sector. For decades, the "Trillion Dollar Club" was an exclusive enclave for Silicon...

Via PredictStreet

Topics Economy Intellectual Property

The Pfizer Pivot: A Deep-Dive into PFE’s 2025 Financial Recovery and Strategic Rebirth

December 22, 2025

As of today, December 22, 2025, Pfizer Inc. (NYSE: PFE) stands as a case study in corporate reinvention and the brutal reality of the post-pandemic "hangover." Once the darling of the global healthcare...

Via PredictStreet

Topics Economy Intellectual Property

Moderna (MRNA): The “Act 2” of an mRNA Pioneer – A 2025 Deep Dive

December 22, 2025

As of December 22, 2025, Moderna, Inc. (NASDAQ: MRNA) stands at a critical juncture in its corporate evolution. Once the poster child for the biotechnology industry’s rapid response to the global...

Via PredictStreet

Topics Earnings Initial Public Offering Intellectual Property

Should You Forget Novo Nordisk and Buy This Magnificent High-Yield Drug Stock Instead? ↗

December 22, 2025

Novo Nordisk gained a head start in the GLP-1 race but then fell behind; Pfizer is working hard to catch up to the new leader.

Via The Motley Fool

MarketBeat Week in Review – 12/15 - 12/19 ↗

December 20, 2025

Via MarketBeat

Better Buy in 2026: Pfizer or Merck? ↗

December 19, 2025

This year has been one to forget for these pharmaceutical giants.

Via The Motley Fool

Topics Intellectual Property

Trump Strikes New Drug-Price Deals With Roche, Novartis, Merck And Other Pharma Giants ↗

December 19, 2025

The deals expand the pricing program to most targeted drugmakers in exchange for temporary tariff relief.

Via Stocktwits

Topics Government World Trade

Dow Jones' Merck, Other Drugmakers Strike Drug-Pricing Bargains With Trump ↗

December 19, 2025

Dow Jones stock Merck forged a Most Favored Nation agreement with the Trump administration on Friday.

Via Investor's Business Daily

Topics Government Stocks

Friday's session: most active stock in the S&P500 index ↗

December 19, 2025

Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Friday and uncover the stocks that are leading the way in terms of trading volume and market...

Via Chartmill

Down 80%, Should You Buy the Dip on Moderna? ↗

December 19, 2025

Your decision on whether to invest now depends to some extent on your investment strategy.

Via The Motley Fool

1 S&P 500 Stock with Impressive Fundamentals and 2 That Underwhelm

December 18, 2025

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...

Via StockStory

Topics Stocks

3 Absurdly Cheap Stocks You Can Buy For Less than $100 Right Now ↗

December 18, 2025

The stocks listed here trade at forward earnings multiples of less than 18.

Via The Motley Fool

Better Buy in 2026: Pfizer or Eli Lilly? ↗

December 18, 2025

These two stocks have been going in opposite directions over the past few years.

Via The Motley Fool

Topics World Trade

Flying Blind: How the Record 43-Day Shutdown Blinded the Fed and Rattled Global Markets

December 18, 2025

The United States economy is finally emerging from a period of unprecedented statistical darkness. Following the conclusion of the longest government shutdown in American history—a 43-day impasse that...

Via MarketMinute

Topics Artificial Intelligence Bonds Credit Cards

The Weight of a Trillion: Inside Eli Lilly’s Pharmaceutical Hegemony

December 18, 2025

On this day in late 2025, Eli Lilly and Company (NYSE: LLY) stands as the undisputed titan of the global pharmaceutical industry. Having crossed the historic $1 trillion market capitalization threshold...

Via PredictStreet

Topics Economy World Trade

Industry Comparison: Evaluating Pfizer Against Competitors In Pharmaceuticals Industry ↗

December 18, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Workboat Indexes

Pfizer (NY:PFE)

Headline News about Pfizer

Groundbreaking held for Bayonne ferry terminal

Coast Guard to restore full operations at its Pascagoula station

Uncrewed ships coming to an ocean near you

Harbour to enter US Gulf through $3.2 billion LLOG acquisition